Company profile

Xaira

Xaira, founded in 2023 and headquartered in San Francisco, California, United States, is an AI-driven drug discovery platform that accelerates development through advanced biological and clinical data generation. The company has raised $1 billion, including a $1 billion Series D in April 2024, led by Arch Venture Partners and Foresite Labs, achieving unicorn status in just one year and three months. Xaira leverages AI for translational and fundamental research, streamlining drug development processes and enhancing R&D productivity for biotech and life sciences innovation.

Back to profiles

Quick facts

Total funding: $1 billion
Founded: 2023
Headquarters: San Francisco, California, United States

Notable investors

Arch Venture Partners
Foresite Labs

Reach buyers like Xaira on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Xaira
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Xaira.

The 14-day trial ships every feature, no card required.

Start free →